2. Apoptosis Immunology/Inflammation
  3. TNF Receptor Apoptosis Interleukin Related Caspase
  4. Golimumab

Golimumab  (Synonyms: 戈利木单抗; CNTO-148)

目录号: HY-P99111 纯度: 99.71%
COA

摩尔计算器

Golimumab (CNTO-148) 是一种有效的人 IgG1 TNFα 拮抗剂单克隆抗体。Golimumab 具有抗炎活性，并抑制 IL-6 和 IL-1β 的产生。Golimumab 通过靶向和中和 TNF 来防止炎症发生和软骨或骨骼的破坏。Golimumab 具有抗癌活性并诱导细胞凋亡 (apoptosis)。Golimumab 可用于类风湿关节炎、克罗恩病和癌症研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

CAS No. : 476181-74-5

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
1 mg ￥2600
In-stock
5 mg ￥7200
In-stock
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

Customer Review

Golimumab 相关抗体

Top Publications Citing Use of Products

查看 TNF Receptor 亚型特异性产品:

查看所有亚型
TNFRSF1A/CD120a TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

查看 Interleukin Related 亚型特异性产品:

查看所有亚型
IL-1 IL-2 IL-3 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-13 IL-15 IL-17 IL-23 IL-7 IL-33 IL-22

查看 Caspase 亚型特异性产品:

查看所有亚型
Caspase 1 Caspase 2 Caspase 3 Caspase 4 Caspase 5 Caspase 6 Caspase 7 Caspase 8 Caspase 9 Caspase 10 Caspase 12 Caspase Caspase 11 Caspase-13

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Golimumab (CNTO-148) is a potent human IgG1 TNFα antagonist monoclonal antibody. Golimumab has anti-inflammation activitity and inhibits IL-6 and IL-1β production. Golimumab acts via targeting and neutralizing TNF to prevent inflammation and destruction of cartilage and bone. Golimumab has the anticancer activity and induces cell apoptosis. Golimumab can be used for rheumatoid arthritis, Crohn's disease and cancer research[1][2][3].

同型

Human IgG1 kappa
推荐同型对照抗体
种属

Human
IC50 & Target[1]

IL-1

 

IL-6

 

CD40

 

体外研究
(In Vitro)

Golimumab (CNTO-148) (0.1-10 μg /mL; 24-72 hours; transmembrane TNFα–transfected Jurkat cells) induces reductions in the viability of transmembrane TNFα–expressing cells[1].
Golimumab (CNTO-148) (10 μg /mL; 48 hours; transmembrane TNFα–transfected Jurkat cells) induces apoptosis, increase the levels of active caspase-3 and induces apoptotic DNA fragmentation[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Golimumab 相关抗体:

Cell Viability Assay[1]

Cell Line: Transmembrane TNFα–transfected Jurkat cells
Concentration: 0.1, 1 and 10 μg/mL
Incubation Time: 24, 48 and 72 hours
Result: Reduced cell viability in a dose- and time-dependent manner.

Apoptosis Analysis[1]

Cell Line: Transmembrane TNFα–transfected Jurkat cells
Concentration: 10 μg /mL
Incubation Time: 48 hours
Result: Had the percentage of apoptotic cells for 30.29%.

Western Blot Analysis[1]

Cell Line: Transmembrane TNFα–transfected Jurkat cells
Concentration: 10 μg /mL
Incubation Time: 48 hours
Result: Increased the levels of active caspase-3 and induces apoptotic DNA fragmentation.
体内研究
(In Vivo)

Golimumab (CNTO-148) (24 mg/kg; i.h.; daily, for 7 days; swiss-albino healthy male mice) inhibits oxidative stress, apoptotic cell death inflammatory response, thus improving renal function. Golimumab reduces all markers of kidney injury and attenuates cell death[2].
Golimumab (CNTO-148) (1-10 mg/kg; i.p.;daily; for 4 weeks; Tg197 transgenic mouse model) relieves TNFα-induced arthritis in a mouse model of human[3].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Swiss-albino healthy male mice[2]
Dosage: 24 mg/kg
Administration: Subcutaneous injection; daily, for 7 days
Result: Reduced serum parameters like BUN, NGAL creatinine, cystatin C, and urinary parameters like KIM-1, NAG, albumin clusterin.
Animal Model: Swiss-albino healthy male mice[2]
Dosage: 24 mg/kg
Administration: Subcutaneous injection; daily, for 7 days
Result: Inhibited oxidative stress, reduces MDA concentrations and increases the GSH and catalase levels.
Animal Model: Swiss-albino healthy male mice[2]
Dosage: 24 mg/kg
Administration: Subcutaneous injection; daily, for 7 days
Result: Inhibitd cisplatin-induced inflammation, decreased TNF-α, including IL-6, IL-1β, MCP-1, ICAM-1, and TGF-β1 levels and increases IL-10 concentrations, reduced caspase 3 in cisplatin injected mice kidneys.
Animal Model: Tg197 transgenic mouse model[3]
Dosage: 1 and 10 mg/kg
Administration: Intraperitoneal injection;for 4 weeks
Result: Reduced the arthritic index.
Clinical Trial
CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

戈利木单抗
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Human IgG1 kappa
纯度 & 产品资料

纯度: 99.71%

COA (264 KB)

抗体抑制剂使用指南 (1152 KB)
参考文献

Golimumab 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Golimumab476181-74-5CNTO-148戈利木单抗CNTO148CNTO 148TNF ReceptorApoptosisInterleukin RelatedCaspaseTumor Necrosis Factor ReceptorTNFRILapoptosisTNFαanticanceranti- inflammation cytokinesInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Golimumab
目录号：
HY-P99111
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z